Aggressive Natural-Killer Cell Lymphoma Presenting with Skin Lesions, Breast Nodule, Suprarenal Masses and Life-Threatening Pericardial and Pleural Effusions

References

• Kanavaros P, De Bruin P C, Briere J, et al. Epstein-Barr virus (EBV) in extranodal T-cell non-Hodgkin's lymphomas (T-NHL). Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV. Leukemia and Lymphoma 1995; 18: 27–34
   Google Scholar
• Kanavaros P, Briere J, Lescs M C, et al. Epstein-Barr virus in non-Hodgkin's lymphomas of the upper respiratory tract: association with sinonasal localization and expression of NK and/or T-cell antigens by tumour cells. Journal of Pathology 1996; 178: 297–302
   PubMed Web of Science ®Google Scholar
• Chan J K, Sin V C, Wong K F, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89: 4501–4513
   PubMed Web of Science ®Google Scholar
• Harabuchi Y, Imai S, Kataura A, et al. Clinical, phenotypic and genotypic aspects of nasal T-cell lymphoma and its causal association with Epstein-Barr virus. Nippon Rinsho 1997; 55: 394–399
   PubMedGoogle Scholar
• Jaffe E S, Krenacs L, Kumar S, et al. Extranodal peripheral T-cell and NK-cell neoplasms. American Journal Clinical Pathology 1999; 111: S46–55
   PubMed Web of Science ®Google Scholar
• Ko Y H, Ree H J, Kim W S, et al. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans. Cancer 2000; 89: 2106–2116
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Yoshino T, Takehisa T, et al. Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological findings of four cases. British Journal of Dermatology 1998; 139: 481–487
   PubMed Web of Science ®Google Scholar
• Hirakawa S, Kuyama M, Takahashi S, et al. Nasal and nasal-type natural killer/T-cell lymphoma. Journal of American Academy of Dermatology 1999; 40: 268–272
   PubMed Web of Science ®Google Scholar
• Kato N, Yasukawa K, Onozuka T, et al. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement. Journal of American Academy Dermatology 1999; 40: 850–856
   PubMed Web of Science ®Google Scholar
• Chan J K, Tsang W Y, Lau W H, et al. Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer 1996; 77: 1198–205
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Tsuzuki T, Nakayama A, et al. A case of natural killer/T cell lymphoma of the subcutis resembling subcutaneous panniculitis-like T cell lymphoma. Pathology International 1999; 49: 241–6
   PubMed Web of Science ®Google Scholar
• Lee Y S, Kang C S, Kim B K, et al. Extranasal T/NK-cell lymphoma presenting as intestinal diverticulum. Journal of Korean Medical Sciences 2000; 15: 229–32
   PubMed Web of Science ®Google Scholar
• Yeh K H, Lien H C, Hsu S M, et al. Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma. American Journal of Hematology 1999; 60: 161–163
   PubMed Web of Science ®Google Scholar
• Chan J K, Tsang W Y, Hui P K, et al. T-and T/natural killer-cell lymphomas of the salivary gland: a clinicopathologic, immunohistochemical and molecular study of six cases. Human Pathology 1997; 28: 238–245
   PubMed Web of Science ®Google Scholar
• Coupland S E, Foss H D, Assaf C, et al. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology 1999; 106: 2109–2120
   PubMed Web of Science ®Google Scholar
• Mhawech P, Medeiros L J, Bueso-Ramos C, et al. Natural killer-cell lymphoma involving the gynecologic tract. Archives of Pathology and Laboratory Medicine 2000; 124: 1510–1513
   PubMed Web of Science ®Google Scholar
• Hisatake J, Koike M, Matsuda I, et al. Nasopharyngeal natural killer cell lymphoma with pericardial infiltration. Nihon Rinsho Meneki Gakkai Kaishi 1996; 19: 145–149
   PubMedGoogle Scholar
• Wong K F, Chan J KC, Ng C S, Lee K C, Tsang W YW, Cheung M M. CD56 (NKHl)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmatic azurophilic granules and angiocentricity. Human Pathology 1992; 23: 798–804
   PubMed Web of Science ®Google Scholar
• Ohno T, Yamaguchi M, Oka K, et al. Frequent expression of CD3 epsilon in CD3 (Leu 4)-negative nasal T-cell lymphomas. Leukemia 1995; 9: 44–52
   PubMed Web of Science ®Google Scholar
• Ohshima K, Suzumiya J, Kanda M, et al. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma. Histopathology 1999; 35: 539–550
   PubMed Web of Science ®Google Scholar
• Ohshima K, Suzumiya J, Sugihara M, et al. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types. Virchows Archives 1999; 435: 92–100
   PubMed Web of Science ®Google Scholar
• Chiang A K, Chan A C, Srivastava G, et al. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK-and T-cell lineage. International Journal of Cancer 1997; 73: 332–338
   PubMed Web of Science ®Google Scholar
• Natkunam Y, Smoller B R, Zehnder J L, et al. Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. American Journal Surgical Pathology 1999; 23: 71–81
   Web of Science ®Google Scholar
• Haedicke W, Ho F C, Chott A, et al. Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood 2000; 95: 3628–3630
   PubMed Web of Science ®Google Scholar
• Mori N, Yatabe Y, Oka K, et al. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation. American Journal of Pathology 1996; 149: 699–705
   Web of Science ®Google Scholar
• Ohshima K, Suzumiya J, Shimazaki K, et al. Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage. Histopathology 1997; 31: 444–50
   PubMed Web of Science ®Google Scholar
• Ng C S, Lo S T, Chan J K, et al. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis?. Human Pathology 1997; 28: 1276–1282
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Yatabe Y, Tsuzuki T, et al. Perforin and granzyme expression in cytotoxic T-cell lymphomas. Modern Pathology 1998; 11: 313–323
   PubMed Web of Science ®Google Scholar
• Ho J W, Liang R H, Srivastava G. Differential cytokine expression in EBV positive peripheral T cell lymphomas. Molecular Pathology 1999; 52: 269–274
   PubMedGoogle Scholar
• Tien H F, Su I J, Tang J L, et al. Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas. British Journal of Haematology 1997; 97: 621–625
   PubMed Web of Science ®Google Scholar
• Wong K F, Chan J K, Ma S K, et al. Aggressive pleomorphic CD2+, CD3-, CD56+ lymphoma with t(5; 9)(q31;q34) abnormality. Cancer Genetics Cytogenetics 1995; 82: 73–5
   PubMed Web of Science ®Google Scholar
• Wong K F, Zhang Y M, Chan J K. Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia—is there a consistent pattern?. Leukemia and Lymphoma 1999; 34: 241–250
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wong K F, Siebert R, et al. Chromosome aberrations are restricted to the CD56+, CD3-tumour cell population in natural killer cell lymphomas: a combined immunophenotyping and FISH study. British Journal of Haematology 1999; 105: 737–42
   PubMed Web of Science ®Google Scholar
• Murphy S B, Bowman W P, Abromowitch M, et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. Journal of Clinical Oncology 1986; 4: 1732–9
   PubMed Web of Science ®Google Scholar